Form 4: Broadwood Partners Increases Stake in STAAR Surgical Co (STAA) Through Open Market Purchases

Broadwood Partners, L.P., along with related entities and individuals, increased its holdings in STAAR Surgical Co. through a series of open market purchases between April 8 and April 10, 2025.

Summary

• Broadwood Partners, L.P., a significant shareholder in STAAR Surgical Co. (STAA), has increased its stake through a series of open market purchases.
• The transactions occurred between April 8 and April 10, 2025.
• The purchases were made at varying prices, ranging from approximately $14.70 to $15.99 per share.
• The total number of shares beneficially owned following these transactions is 13,519,491.
• The reporting parties include Broadwood Partners, L.P., Broadwood Capital, Inc. (as General Partner), and Neal C. Bradsher (as President of Broadwood Capital).
• Neal C. Bradsher also directly owns 25,900 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock purchases. The increased stake could be interpreted as a positive signal, but it's not definitive.

Positives

• Increased investment by a major shareholder could signal confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in trading activities by company insiders and major shareholders. They provide insights into the sentiment and actions of those with privileged information about the company.

Stakeholder Impact

• The increased stake by Broadwood Partners could be viewed positively by shareholders, potentially increasing investor confidence.

Key Dates

Keywords

STAAR Surgical, Broadwood Partners, Insider Trading, Beneficial Ownership, Form 4, Stock Purchase, STAA